Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results
Artivion Inc AORT
$26.83
▼ -3.04%
($-0.84)
⬇️ Below Yest. Low
📅 Earnings This Week
Open
$27.21
Prev Close
$27.67
Day Range
$26.61 – $27.56
52W Range
$19.16 – $48.25
Market Cap
$1.30B
P/E (TTM)
111.70
Beta
1.27
EPS (TTM)
$0.24
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1993-02-12 |
| Shares Out. | 48,540,000 |
| Website | artivion.com/ ↗ |
| Phone | 17704193355 |
| Employees | 1,800 |
| Revenue | $116.3M |
| Gross Profit | $75.4M |
| Net Income | $1.4M |
| Free Cash Flow | $14.6M |
| Total Assets | $883.2M |
| Total Liabilities | $432.7M |
| Equity | $450.5M |
About Artivion Inc
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Artivion Inc is a publicly traded company under the ticker symbol AORT on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-07-01)